biological · Product Intelligence

Bevacizumab
Pipeline Intelligence

Bevacizumab: 5 indexed trials, 5 sponsors; 0 linked Orange Book patents and 0 FDA-linked events where matched.

⚗
5Indexed trials
▦
5Sponsors
⌁
0Orange Book patent links
◎
0FDA-linked events

Development evidence

NCT01621880Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · out_of_scopePHASE2
NCT01933815Cortice Biosciences, Inc. · neuro_oncologyPHASE1, PHASE2
NCT03425292Saint John's Cancer Institute · neuro_oncologyPHASE1
NCT06888817The Netherlands Cancer Institute · neuro_oncologyPHASE3
NCT07216703Merck Sharp & Dohme LLC · parkinsonsPHASE3

FDA / patent evidence

No FDA Orange Book product match is asserted for this intervention.

Regulatory context

FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.